## **Core Concept**
Phenylketonuria (PKU) is a genetic disorder characterized by the inability to break down the amino acid phenylalanine (Phe), due to a deficiency in the enzyme **phenylalanine hydroxylase**. This leads to the accumulation of Phe in the body, which can cause intellectual disability and other serious health problems if not treated. The primary treatment involves dietary restrictions and, in some cases, enzyme replacement therapy.

## **Why the Correct Answer is Right**
The correct approach to the treatment of PKU involves a strict dietary control of phenylalanine intake. This typically starts early in life and involves a special diet that limits the intake of phenylalanine. Foods high in protein and certain artificial sweeteners contain phenylalanine and must be avoided. In addition to dietary control, some patients may benefit from **sapropterin dihydrochloride**, a synthetic form of tetrahydrobiopterin (BH4), which is a cofactor for phenylalanine hydroxylase. This can help reduce phenylalanine levels in some individuals with PKU who are responsive to BH4.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but generally, incorrect options might suggest treatments that are not evidence-based or not specifically tailored to PKU management, such as insulin for diabetes or antihistamines for allergies.
- **Option B:** Similarly, without the content, we can infer that any option suggesting a treatment not directly related to phenylalanine restriction or BH4 supplementation would be incorrect.
- **Option D:** This would also be incorrect based on the same reasoning, as effective management of PKU is quite specific.

## **Clinical Pearl / High-Yield Fact**
A critical aspect of PKU management is early diagnosis and intervention. Newborn screening programs often include PKU testing, allowing for early initiation of dietary restrictions. Additionally, **pregnant women with PKU must maintain strict dietary control** to prevent maternal PKU syndrome, which can cause severe birth defects and developmental delays in the fetus.

## **Correct Answer:** . Tetrahydrobiopterin (BH4) supplementation